— Know what they know.
Not Investment Advice

TARS NASDAQ

Tarsus Pharmaceuticals, Inc.
1W: -2.6% 1M: +0.0% 3M: -4.7% YTD: -21.4% 1Y: +41.4% 3Y: +290.6% 5Y: +115.5%
$62.26
-1.22 (-1.92%)
 
Weekly Expected Move ±6.7%
$54 $58 $62 $67 $71
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 47 · $2.7B mcap · 40M float · 1.55% daily turnover · Short 66% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -202.8%  ·  5Y Avg: -0.2%
Cost Advantage
59
Intangibles
33
Switching Cost
58
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TARS shows a Weak competitive edge (50.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -202.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$81
Avg Target
$81
High
Based on 5 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 1Buy: 7Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$81.40
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-05 Goldman Sachs $51 $68 +17 +5.3% $64.59
2025-12-08 Barclays $62 $100 +38 +21.6% $82.23
2025-11-20 Mizuho Securities Initiated $100 +29.7% $77.11
2025-11-06 Goldman Sachs Andrea Tan Initiated $51 -24.2% $67.25
2025-10-20 H.C. Wainwright $61 $88 +27 +20.7% $72.93
2025-05-02 Guggenheim Eddie Hickman Initiated $84 +77.4% $47.36
2025-03-06 Jefferies Initiated $58 +33.1% $43.57
2025-01-27 Barclays Balaji Prasad Initiated $62 +27.1% $48.78
2025-01-22 Oppenheimer Francois Brisebois $63 $72 +9 +52.7% $47.14
2024-09-23 Oppenheimer Francois Brisebois Initiated $63 +82.2% $34.58
2024-05-13 H.C. Wainwright Oren Livnat Initiated $61 +64.9% $37.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TARS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

51 Grade D
Profitability
20
Balance Sheet
62
Earnings Quality
53
Growth
88
Value
29
Momentum
80
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TARS scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
8.74
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-1.89
Unlikely Manipulator
Ohlson O-Score
-7.71
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 62.5/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.34x
Accruals: -6.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TARS scores 8.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TARS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TARS's score of -1.89 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TARS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TARS receives an estimated rating of BBB+ (score: 62.5/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-55.41x
PEG
-0.54x
P/S
5.01x
P/B
7.66x
P/FCF
-95.55x
P/OCF
EV/EBITDA
-68.77x
EV/Revenue
5.03x
EV/EBIT
-65.75x
EV/FCF
-85.28x
Earnings Yield
-1.60%
FCF Yield
-1.05%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TARS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.994
NI / EBT
×
Interest Burden
1.187
EBT / EBIT
×
EBIT Margin
-0.076
EBIT / Rev
×
Asset Turnover
1.139
Rev / Assets
×
Equity Multiplier
1.654
Assets / Equity
=
ROE
-17.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TARS's ROE of -17.0% is driven by Asset Turnover (1.139), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.99 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1406 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$62.26
Median 1Y
$61.88
5th Pctile
$20.26
95th Pctile
$189.42
Ann. Volatility
64.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Bobak Azamian, M.D.,
Ph.D. President, Chief Executive Officer and Board Chairman
$726,333 $2,648,284 $6,617,979
Aziz Mottiwala Commercial
ercial Officer
$529,250 $983,361 $2,789,529
Jeffrey Farrow Financial
ancial Officer and Chief Strategy Officer
$541,667 $893,961 $2,677,617
Seshadri Neervannan, Ph.D.
Chief Operating Officer
$547,000 $893,961 $2,628,172
Bryan Wahl, M.D.,
J.D General Counsel
$500,833 $893,961 $2,560,205

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,617,979
Avg Employee Cost (SGA/emp): $1,154,927
Employees: 370

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
370
+14.6% YoY
Revenue / Employee
$1,219,892
Rev: $451,360,000
Profit / Employee
$-179,508
NI: $-66,418,000
SGA / Employee
$1,154,927
Avg labor cost proxy
R&D / Employee
$173,843
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 3.1% -6.4% -8.4% -26.7% -34.0% -38.1% -34.5% -36.3% -50.6% -59.8% -69.7% -76.0% -77.0% -68.9% -54.8% -49.8% -43.6% -38.5% -23.4% -17.0% -17.00%
ROA 3.0% -6.2% -8.0% -25.4% -32.2% -36.1% -30.5% -32.1% -44.7% -52.9% -55.1% -60.1% -60.8% -54.5% -36.0% -32.7% -28.6% -25.3% -14.1% -10.3% -10.28%
ROIC -4.6% 5.5% 3.0% 10.5% 13.6% 15.4% 12.6% 13.7% 19.3% 22.9% 477.2% 519.6% 521.2% 468.7% -17.0% -15.4% -13.8% -12.3% -2.8% -2.0% -2.03%
ROCE 3.4% -6.3% -8.0% -26.3% -33.2% -36.7% -28.2% -29.6% -41.5% -49.2% -58.0% -63.3% -63.5% -55.9% -36.3% -32.3% -27.9% -25.1% -13.5% -9.6% -9.59%
Gross Margin 96.7% 94.8% 1.1% 93.9% 96.6% 96.0% 1.0% 79.9% 90.7% 94.0% 92.6% 93.3% 92.6% 93.3% 93.9% 79.3% 92.8% 94.2% 94.20%
Operating Margin 33.1% -12.7% -42.7% -36.2% -34.2% -1.5% -10.0% -21.9% -3.4% -1.4% -81.6% -52.3% -36.8% -33.5% -21.6% -12.2% -5.3% -3.8% -3.78%
Net Margin 28.6% -12.7% -43.9% -37.5% -37.6% -1.4% -9.4% -20.9% -3.2% -1.3% -81.6% -48.7% -34.8% -32.1% -19.8% -10.6% -5.5% -4.3% -4.30%
EBITDA Margin 29.7% -12.9% -42.6% -36.9% -33.4% -1.3% -9.1% -20.4% -3.1% -1.2% -75.8% -43.0% -30.7% -28.7% -17.2% -10.2% -2.4% -3.5% -3.51%
FCF Margin -2.5% 9.9% 5.5% -1.3% -1.5% -3.2% -1.9% -2.0% -6.1% -6.6% -7.0% -3.3% -1.6% -78.4% -49.0% -31.2% -29.7% -17.1% -4.9% -5.9% -5.89%
OCF Margin -2.3% 10.3% 6.6% 1.1% -1.4% -3.1% -1.9% -2.0% -6.0% -6.2% -6.7% -3.1% -1.5% -77.3% -45.4% -28.2% -27.4% -14.7% -2.8% -3.1% -3.07%
ROE 3Y Avg snapshot only -45.34%
ROE 5Y Avg snapshot only -39.31%
ROA 3Y Avg snapshot only -30.75%
ROIC Economic snapshot only -9.41%
Cash ROA snapshot only -2.93%
Cash ROIC snapshot only -83.12%
CROIC snapshot only -1.59%
NOPAT Margin snapshot only -7.50%
Pretax Margin snapshot only -9.07%
R&D / Revenue snapshot only 13.51%
SGA / Revenue snapshot only 89.47%
SBC / Revenue snapshot only 6.50%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 124.38 -42.05 -33.25 -7.83 -6.28 -7.21 -6.06 -5.15 -5.33 -5.06 -4.76 -8.66 -6.85 -9.40 -18.48 -19.26 -18.65 -31.20 -52.74 -62.44 -55.413
P/S Ratio 11.48 7.85 8.14 14.43 20.42 28.26 14.58 12.10 38.76 37.87 37.08 30.15 12.33 9.74 11.67 8.65 5.81 6.92 7.76 5.63 5.006
P/B Ratio 3.84 2.68 2.78 2.09 2.13 2.74 1.95 1.74 2.51 2.82 3.28 6.51 5.22 6.41 9.51 9.00 7.64 11.28 10.20 8.77 7.664
P/FCF -455.69 79.52 146.81 -1102.36 -14.08 -8.96 -7.60 -5.96 -6.32 -5.75 -5.26 -9.25 -7.94 -12.42 -23.83 -27.74 -19.54 -40.49 -157.02 -95.55 -95.546
P/OCF 75.96 123.86 1360.73
EV/EBITDA 79.51 -27.61 -22.60 -4.08 -3.35 -4.68 -3.01 -2.23 -3.28 -3.34 -3.41 -7.56 -5.77 -8.41 -18.00 -19.08 -18.45 -31.87 -56.90 -68.77 -68.768
EV/Revenue 8.46 4.90 5.16 7.39 10.65 17.74 6.96 5.02 23.02 24.17 25.77 25.52 9.96 8.22 10.47 7.71 5.07 6.32 7.04 5.03 5.027
EV/EBIT 84.01 -26.55 -21.93 -4.05 -3.33 -4.66 -3.00 -2.22 -3.26 -3.32 -3.39 -7.51 -5.72 -8.33 -17.79 -18.80 -18.08 -31.10 -55.11 -65.75 -65.754
EV/FCF -335.93 49.61 93.07 -564.63 -7.35 -5.63 -3.63 -2.47 -3.75 -3.67 -3.66 -7.83 -6.42 -10.48 -21.39 -24.73 -17.05 -36.99 -142.52 -85.28 -85.285
Earnings Yield 0.8% -2.4% -3.0% -12.8% -15.9% -13.9% -16.5% -19.4% -18.8% -19.8% -21.0% -11.5% -14.6% -10.6% -5.4% -5.2% -5.4% -3.2% -1.9% -1.6% -1.60%
FCF Yield -0.2% 1.3% 0.7% -0.1% -7.1% -11.2% -13.2% -16.8% -15.8% -17.4% -19.0% -10.8% -12.6% -8.1% -4.2% -3.6% -5.1% -2.5% -0.6% -1.0% -1.05%
Price/Tangible Book snapshot only 8.967
EV/Gross Profit snapshot only 5.558
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 31.68 31.68 15.33 15.33 15.33 15.33 14.61 14.61 14.61 14.61 6.93 6.93 6.93 6.93 4.42 4.42 4.42 4.42 3.85 3.85 3.853
Quick Ratio 31.68 31.68 15.33 15.33 15.33 15.33 14.61 14.61 14.61 14.61 6.85 6.85 6.85 6.85 4.39 4.39 4.39 4.39 3.82 3.82 3.820
Debt/Equity 0.01 0.01 0.01 0.01 0.01 0.01 0.10 0.10 0.10 0.10 0.15 0.15 0.15 0.15 0.32 0.32 0.32 0.32 0.27 0.27 0.273
Net Debt/Equity -1.01 -1.01 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.00 -1.00 -1.00 -1.00 -0.98 -0.98 -0.98 -0.98 -0.94 -0.94 -0.942
Debt/Assets 0.00 0.00 0.01 0.01 0.01 0.01 0.09 0.09 0.09 0.09 0.11 0.11 0.11 0.11 0.19 0.19 0.19 0.19 0.17 0.17 0.167
Debt/EBITDA 0.14 -0.08 -0.15 -0.04 -0.03 -0.03 -0.34 -0.32 -0.23 -0.19 -0.23 -0.21 -0.21 -0.24 -0.68 -0.77 -0.89 -1.00 -1.68 -2.39 -2.394
Net Debt/EBITDA -28.35 16.64 13.05 3.89 3.07 2.78 3.30 3.15 2.24 1.89 1.50 1.37 1.37 1.56 2.06 2.32 2.70 3.02 5.79 8.27 8.274
Interest Coverage -139.34 -64.66 -41.19 -27.44 -24.60 -31.24 -34.31 -39.63 -39.67 -29.39 -19.98 -14.21 -11.05 -9.56 -11.73 -9.04 -6.36 -6.356
Equity Multiplier 1.04 1.04 1.07 1.07 1.07 1.07 1.18 1.18 1.18 1.18 1.35 1.35 1.35 1.35 1.68 1.68 1.68 1.68 1.64 1.64 1.637
Cash Ratio snapshot only 3.075
Debt Service Coverage snapshot only -6.077
Cash to Debt snapshot only 4.456
FCF to Debt snapshot only -0.337
Defensive Interval snapshot only 344.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.32 0.33 0.33 0.14 0.10 0.09 0.13 0.14 0.06 0.07 0.07 0.17 0.34 0.53 0.57 0.73 0.92 1.14 0.96 1.14 1.139
Inventory Turnover 1.03 2.09 4.02 5.87 4.48 5.72 6.85 14.31 13.43 14.63 14.632
Receivables Turnover 2772.45 2834.45 1018.34 430.96 310.61 288.46 14.05 15.12 6.80 7.82 1.73 4.21 8.25 12.83 5.77 7.37 9.33 11.55 6.85 8.12 8.119
Payables Turnover 0.91 0.94 0.81 0.32 0.23 0.21 0.23 0.22 0.10 0.19 0.14 0.28 0.54 0.78 0.56 0.72 0.86 1.80 2.13 2.32 2.318
DSO 0 0 0 1 1 1 26 24 54 47 211 87 44 28 63 50 39 32 53 45 45.0 days
DIO 0 0 0 0 0 0 0 0 0 0 356 175 91 62 81 64 53 26 27 25 24.9 days
DPO 401 389 448 1146 1560 1750 1596 1654 3812 1962 2666 1308 679 466 648 507 423 203 171 157 157.4 days
Cash Conversion Cycle -401 -389 -448 -1145 -1558 -1749 -1570 -1629 -3758 -1916 -2099 -1047 -544 -375 -503 -394 -331 -146 -91 -88 -87.5 days
Fixed Asset Turnover snapshot only 24.607
Operating Cycle snapshot only 69.9 days
Cash Velocity snapshot only 1.282
Capital Intensity snapshot only 1.051
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -27.8% -68.6% -71.5% -54.7% 15.1% -28.1% -11.0% -32.4% 53.2% 5.7% 8.0% 9.5% 4.5% 2.5% 1.8% 1.5% 1.3% 1.29%
Net Income -21.8% -36.7% -12.0% -5.0% -3.4% -46.7% -60.9% -69.9% -1.2% -1.3% -65.0% -24.9% 15.0% 29.2% 38.7% 39.6% 42.5% 54.0% 54.01%
EPS -24.4% -38.7% -11.0% -3.6% -2.6% -13.6% -46.0% -47.9% -75.9% -72.0% -17.0% 0.4% 29.6% 36.5% 45.3% 45.6% 48.2% 57.9% 57.88%
FCF 1.3% 98.6% -17.1% -10.1% -16.7% -177.5% -2.0% -85.9% -1.5% -1.5% -69.0% -7.4% 27.2% 47.4% 32.2% 38.5% 75.1% 56.7% 56.72%
EBITDA -13.9% -67.2% -10.4% -5.1% -3.6% -42.8% -58.5% -69.8% -1.2% -1.3% -64.2% -21.8% 19.2% 34.2% 43.7% 42.7% 47.5% 58.6% 58.58%
Op. Income -5.9% -54.6% -9.4% -5.8% -4.2% -60.7% -74.4% -83.2% -1.3% -1.3% -63.3% -23.6% 15.8% 30.0% 37.3% 37.8% 41.1% 53.5% 53.45%
OCF Growth snapshot only 75.03%
Asset Growth snapshot only 49.12%
Equity Growth snapshot only 52.95%
Debt Growth snapshot only 29.24%
Shares Change snapshot only 9.18%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 8.4% 14.6% 31.7% 47.5% 1.1% 1.6% 1.8% 1.6% 1.7% 1.68%
Revenue 5Y 74.1% 74.12%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 7.0% 13.0% 30.2% 45.7% 1.1% 1.5% 1.8% 1.5% 1.6% 1.62%
Gross Profit 5Y 72.0% 72.01%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 15.6% 15.6% 15.6% 15.6% 28.2% 28.2% 28.2% 28.2% 35.1% 35.1% 35.12%
Assets 5Y 26.7% 26.7% 26.73%
Equity 3Y 5.9% 5.9% 5.9% 5.9% 10.4% 10.4% 10.4% 10.4% 21.2% 21.2% 21.20%
Book Value 3Y -7.8% -9.8% -11.7% -13.9% -10.3% -10.8% -8.2% -5.5% 2.2% 3.5% 3.49%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.20 0.36 0.83 0.78 0.01 0.25 0.09 0.27 0.39 0.67 0.77 0.83 0.66 0.64 0.640
Earnings Stability 0.79 0.96 0.97 1.00 0.87 0.93 0.99 0.98 0.84 0.76 0.64 0.51 0.47 0.27 0.270
Margin Stability 1.00 1.00 0.99 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.96 0.97 0.97 0.972
Rev. Growth Consistency 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.81 0.50 0.50 0.50 0.50 0.50 0.90 0.94 0.88 0.85 0.84 0.83 0.50 0.500
Earnings Smoothness
ROE Trend -0.25 -0.20 -0.32 -0.34 -0.49 -0.45 -0.36 -0.21 -0.01 0.08 0.21 0.26 0.41 0.47 0.469
Gross Margin Trend 0.00 0.00 -0.02 -0.05 -0.04 -0.04 -0.03 -0.01 -0.02 -0.01 -0.05 -0.02 -0.02 -0.022
FCF Margin Trend -1.70 -5.39 -5.06 -6.12 -2.24 2.24 4.09 3.99 2.33 3.54 3.51 3.72 1.73 1.726
Sustainable Growth Rate 3.1%
Internal Growth Rate 3.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.25 -0.55 -0.27 -0.01 0.43 0.79 0.79 0.85 0.83 0.83 0.86 0.90 0.83 0.75 0.72 0.63 0.88 0.66 0.19 0.34 0.341
FCF/OCF 1.11 0.96 0.84 -1.23 1.03 1.01 1.01 1.01 1.02 1.06 1.05 1.04 1.05 1.01 1.08 1.11 1.09 1.16 1.79 1.92 1.917
FCF/Net Income snapshot only 0.653
CapEx/Revenue 0.3% 0.6% 1.0% 2.4% 3.9% 4.0% 2.0% 2.5% 10.8% 39.2% 31.5% 12.5% 6.7% 1.2% 3.6% 3.0% 2.4% 2.3% 2.2% 2.8% 2.82%
CapEx/Depreciation snapshot only 8.414
Accruals Ratio 0.04 -0.10 -0.10 -0.26 -0.18 -0.07 -0.06 -0.05 -0.08 -0.09 -0.07 -0.06 -0.11 -0.14 -0.10 -0.12 -0.03 -0.08 -0.11 -0.07 -0.068
Sloan Accruals snapshot only 0.233
Cash Flow Adequacy snapshot only -1.090
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio 0.0% 0.0%
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -14.4% -20.7% -0.0% -0.0% -21.0% -16.3% -19.9% -22.3% -0.1% -18.5% -18.6% -17.8% -22.5% -10.4% -5.4% -7.1% -8.3% -5.7% -4.1% -0.3% -0.27%
Total Shareholder Return -14.4% -20.7% -0.0% -0.0% -21.0% -16.3% -19.9% -22.3% -0.1% -18.5% -18.6% -17.8% -22.5% -10.4% -5.4% -7.1% -8.3% -5.7% -4.1% -0.3% -0.27%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.91 1.01 1.01 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.03 0.99 0.994
Interest Burden (EBT/EBIT) 1.00 1.00 1.03 1.02 1.02 1.03 1.04 1.04 1.03 1.03 1.02 1.02 1.03 1.05 1.07 1.09 1.11 1.09 1.12 1.19 1.187
EBIT Margin 0.10 -0.18 -0.24 -1.82 -3.20 -3.81 -2.32 -2.26 -7.06 -7.28 -7.60 -3.40 -1.74 -0.99 -0.59 -0.41 -0.28 -0.20 -0.13 -0.08 -0.076
Asset Turnover 0.32 0.33 0.33 0.14 0.10 0.09 0.13 0.14 0.06 0.07 0.07 0.17 0.34 0.53 0.57 0.73 0.92 1.14 0.96 1.14 1.139
Equity Multiplier 1.04 1.04 1.05 1.05 1.05 1.05 1.13 1.13 1.13 1.13 1.27 1.27 1.27 1.27 1.52 1.52 1.52 1.52 1.65 1.65 1.654
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.23 $-0.51 $-0.68 $-2.15 $-2.32 $-2.38 $-2.42 $-2.44 $-3.39 $-3.51 $-4.25 $-4.20 $-3.97 $-3.50 $-3.00 $-2.67 $-2.17 $-1.90 $-1.55 $-1.12 $-1.12
Book Value/Share $7.56 $8.04 $8.08 $8.05 $6.85 $6.25 $7.51 $7.21 $7.19 $6.30 $6.17 $5.58 $5.21 $5.13 $5.82 $5.71 $5.30 $5.27 $8.03 $7.99 $8.12
Tangible Book/Share $7.56 $8.04 $8.08 $8.05 $6.85 $6.25 $7.51 $7.21 $7.19 $6.30 $6.05 $5.47 $5.11 $5.03 $5.61 $5.50 $5.10 $5.07 $7.85 $7.82 $7.82
Revenue/Share $2.52 $2.75 $2.76 $1.17 $0.71 $0.61 $1.01 $1.04 $0.47 $0.47 $0.55 $1.21 $2.20 $3.38 $4.74 $5.94 $6.98 $8.59 $10.55 $12.46 $12.46
FCF/Share $-0.06 $0.27 $0.15 $-0.02 $-1.04 $-1.91 $-1.93 $-2.11 $-2.86 $-3.09 $-3.85 $-3.93 $-3.42 $-2.65 $-2.32 $-1.85 $-2.07 $-1.47 $-0.52 $-0.73 $-0.73
OCF/Share $-0.06 $0.28 $0.18 $0.01 $-1.01 $-1.89 $-1.91 $-2.08 $-2.81 $-2.91 $-3.68 $-3.78 $-3.28 $-2.61 $-2.15 $-1.67 $-1.91 $-1.27 $-0.29 $-0.38 $-0.38
Cash/Share $7.65 $8.15 $8.33 $8.30 $7.06 $6.44 $8.45 $8.12 $8.09 $7.09 $7.12 $6.44 $6.01 $5.93 $7.56 $7.41 $6.88 $6.84 $9.75 $9.71 $9.05
EBITDA/Share $0.27 $-0.49 $-0.63 $-2.11 $-2.27 $-2.30 $-2.32 $-2.33 $-3.27 $-3.40 $-4.12 $-4.07 $-3.81 $-3.30 $-2.76 $-2.40 $-1.92 $-1.70 $-1.31 $-0.91 $-0.91
Debt/Share $0.04 $0.04 $0.09 $0.09 $0.08 $0.07 $0.79 $0.76 $0.75 $0.66 $0.95 $0.86 $0.80 $0.79 $1.88 $1.84 $1.71 $1.70 $2.19 $2.18 $2.18
Net Debt/Share $-7.62 $-8.11 $-8.24 $-8.20 $-6.98 $-6.37 $-7.66 $-7.36 $-7.34 $-6.43 $-6.17 $-5.59 $-5.21 $-5.14 $-5.68 $-5.56 $-5.17 $-5.14 $-7.56 $-7.53 $-7.53
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 8.742
Altman Z-Prime snapshot only 16.020
Piotroski F-Score 2 3 5 4 2 2 2 4 2 2 2 3 3 4 5 4 5 4 5 5 5
Beneish M-Score 245.81 6.39 23.20 7.38 1.67 7.69 20.13 0.95 -0.77 -0.63 -0.77 -1.97 -1.89 -1.894
Ohlson O-Score snapshot only -7.705
ROIC (Greenblatt) snapshot only -10.01%
Net-Net WC snapshot only $7.08
EVA snapshot only $-42120090.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 86.62 81.44 82.23 66.19 63.30 63.72 65.60 65.10 65.27 65.44 62.25 65.32 65.62 65.55 63.75 63.97 63.98 63.64 62.90 62.50 62.498
Credit Grade snapshot only 8
Credit Trend snapshot only -1.475
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 57
Sector Credit Rank snapshot only 55

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms